SLC6A2 and digestive system neoplasm: Recently, we showed that nonradiolabelled MIBG specifically inhibited the growth of norepinephrine transporter (NET)-positive NE gastrointestinal tumour cells with an IC50 value of 7.8 μM (Höpfner et al, 2002).